Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M)

by Ahrén, Bo, Leguizamo Dimas, Aniceto, Miossec, Patrick, Saubadu, Stéphane, Aronson, Ronnie
Published 2013

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-week, randomized, placebo-controlled comparison (GetGoal-L)

by Riddle, Matthew C., Aronson, Ronnie, Home, Philip, Marre, Michel, Niemoeller, Elisabeth, Miossec, Patrick, Ping, Lin, Ye, Jenny, Rosenstock, Julio
Published 2013

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: A 24-week, randomized, placebo-con...

by Riddle, Matthew C., Forst, Thomas, Aronson, Ronnie, Sauque-Reyna, Leobardo, Souhami, Elisabeth, Silvestre, Louise, Ping, Lin, Rosenstock, Julio
Published 2013

Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes

by Aronson, Ronnie, Gottlieb, Peter A., Christiansen, Jens S., Donner, Thomas W., Bosi, Emanuele, Bode, Bruce W., Pozzilli, Paolo
Published 2014

The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study

by Conget, Ignacio, Castaneda, Javier, Petrovski, Goran, Guerci, Bruno, Racault, Anne-Sophie, Reznik, Yves, Cohen, Ohad, Runzis, Sarah, de Portu, Simona, Aronson, Ronnie
Published 2016